These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 2284757)

  • 41. [Enkephalins and endorphins in unstable stenocardia].
    Matsak VV
    Vrach Delo; 1990 Jan; (1):59-61. PubMed ID: 2330714
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Thromboxane A2 and prostacyclin in patients with chronic glomerulonephritis and coronary heart disease in contrast media nephrotoxicity. Protective effects of calcium antagonists].
    Dzgoeva FU; Kutyrina IM
    Ter Arkh; 2000; 72(6):42-5. PubMed ID: 10900648
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Various indices of lipid peroxidation in thrombocytes of patients with ischemic heart disease].
    Shatilina LV; Balliuzek MF; Gurevich VS
    Vopr Med Khim; 1988; 34(2):59-61. PubMed ID: 3400192
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [The use of finoptin and alpha-tocopherol in patients with stable exertional stenocardia].
    Levchenko VA; Serediuk NN; Gereliuk IP; Vakaliuk IP; Bondar' MM
    Vrach Delo; 1990 Jan; (1):61-4. PubMed ID: 2330715
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Platelet hyperactivity in acute myocardial infarction in man--effects of prostacyclin.
    Mueller HS; Rao PS; Greenberg MA; Buttrick PM; Sussman II; Levite HA; Grose RM; Perez-Davila V; Strain JE; Spaet TH
    Herz; 1986 Apr; 11(2):116-26. PubMed ID: 2939012
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Functional status of thrombocytes in patients with acute forms of ischemic heart disease].
    Kakuliia MSh; Panchenko VM
    Klin Med (Mosk); 1987 Jan; 65(1):88-92. PubMed ID: 3560837
    [No Abstract]   [Full Text] [Related]  

  • 47. [Effect of the prostacyclin analog taprostene on ischemic ST-segment depression in the stress ECG of coronary patients].
    Hopf R; Schöfl E; Frings M; Söhngen W
    Z Kardiol; 1994 Apr; 83(4):258-63. PubMed ID: 8023538
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Changes in systemic blood viscosity during the exercise test in angina pectoris].
    Forconi S; Guerrini M; Rossi C; Pecchi S; Di Perri T
    Boll Soc Ital Cardiol; 1977; 22(4):435-40. PubMed ID: 617289
    [No Abstract]   [Full Text] [Related]  

  • 49. [Vascular action of prostaglandins: atheroma, vasoconstriction and ischemia].
    Montalescot G
    Arch Mal Coeur Vaiss; 1992 Sep; 85 Spec No 2():181-3. PubMed ID: 1285701
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Reduced prostacyclin production in patients with different manifestations of ischemic heart disease.
    Serneri GG; Masotti G; Poggesi L; Galanti G; Morettini A; Scarti L
    Am J Cardiol; 1982 Apr; 49(5):1146-51. PubMed ID: 7039288
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Unstable stenocardia: functional activity and free cytoplasmic calcium of thrombocytes and vaso- and thrombocytoactive prostanoids].
    Panchenko EP; Shalaev SV; Gratsianskiĭ NA; Giorgadze ML; Popov IuM
    Kardiologiia; 1987 Oct; 27(10):27-32. PubMed ID: 3695081
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Analogs of prostaglandin-related substances and inhibitors of their synthesis and metabolism. Clinical application: cardiovascular diseases].
    Ogawa K; Ito T
    Nihon Rinsho; 1985 Mar; 43(3):578-82. PubMed ID: 3892088
    [No Abstract]   [Full Text] [Related]  

  • 53. Comparison of plasma concentrations of thromboxane B2 in Prinzmetal's variant angina and classical angina pectoris.
    Lewy RI; Wiener L; Smith JB; Walinsky P; Silver MJ; Saia J
    Clin Cardiol; 1979 Dec; 2(6):404-6. PubMed ID: 544110
    [No Abstract]   [Full Text] [Related]  

  • 54. [Mechanisms of the effects of physical training on the functional state of blood platelets in patients with ischemic heart disease].
    Dudaev VA; Diukov IV; Borodkin VV
    Kardiologiia; 1990 Aug; 30(8):20-3. PubMed ID: 2255135
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [A comparative evaluation of the effect of stress and physical loading on the coagulating capacity of the blood in clinically healthy subjects and ischemic heart disease patients].
    Khalfen ESh; Liamina NP; Meerson FZ
    Ter Arkh; 1990; 62(8):50-3. PubMed ID: 2274869
    [No Abstract]   [Full Text] [Related]  

  • 56. [The effect of plasmapheresis and antianginal therapy on lipid metabolism, eicosanoids and the thrombocytic link of hemostasis in patients with ischemic heart disease].
    Topchiĭ II; Volkov VI; Kidon' VP; Kravchenko IG
    Lik Sprava; 1993; (2-3):50-3. PubMed ID: 8191735
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Effect of polyunsaturated fatty acids on the functional properties of the thrombocytes and on lipid peroxidation in ischemic heart disease patients].
    Dudaev VA; Abbud A; Ivanov AS
    Kardiologiia; 1987 Jun; 27(6):79-83. PubMed ID: 3626287
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Physical activity and prostanoids.
    Rauramaa R
    Acta Med Scand Suppl; 1986; 711():137-42. PubMed ID: 3535405
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [The prostaglandin-prostacyclin system and thrombocyte functions in patients with systemic lupus erythematosus].
    Pribytkov IuN; Poltyrev AS; Shilkina NP
    Ter Arkh; 1992; 64(12):44-8. PubMed ID: 1292132
    [No Abstract]   [Full Text] [Related]  

  • 60. [Phenotypic familial correlations of prostacyclin and thromboxane A2 levels in children and adolescents with or without hereditary predisposition to ischemic heart disease].
    Akimov EV
    Kardiologiia; 1992 May; 32(5):41-3. PubMed ID: 1405259
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.